StonvexLoading…
StonvexCore line items from TSAT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | C$417.96M | C$571.04M | C$704.16M | C$759.17M |
Operating Income | C$-303.88M | C$-40.27M | C$568.85M | C$296.45M |
Net Income | C$-530.22M | C$-302.47M | C$583.27M | C$-81.60M |
EPS (Diluted) | C$-10.61 | C$-6.29 | C$11.29 | C$-1.93 |
Total Assets | C$6.60B | C$6.95B | C$6.31B | C$6.48B |
Total Liabilities | C$4.83B | C$4.45B | C$3.91B | C$4.64B |
Cash & Equivalents | C$509.80M | C$552.06M | C$1.67B | C$1.68B |
Free Cash Flow OCF − CapEx | C$-73.82M | C$-2.34M | C$127.14M | C$206.85M |
Shares Outstanding | 14.84M | 14.19M | 13.61M | 12.81M |